KBC Group NV cut its stake in Monsanto Company (NYSE:MON) by 2.7% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 88,381 shares of the basic materials company’s stock after selling 2,415 shares during the period. KBC Group NV’s holdings in Monsanto were worth $10,589,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently made changes to their positions in the stock. Puplava Financial Services Inc. lifted its position in Monsanto by 0.4% in the second quarter. Puplava Financial Services Inc. now owns 2,119 shares of the basic materials company’s stock valued at $251,000 after acquiring an additional 9 shares during the last quarter. Enterprise Financial Services Corp raised its holdings in shares of Monsanto by 1.2% in the second quarter. Enterprise Financial Services Corp now owns 1,384 shares of the basic materials company’s stock valued at $164,000 after buying an additional 16 shares during the last quarter. Forward Management LLC raised its holdings in shares of Monsanto by 0.5% in the second quarter. Forward Management LLC now owns 3,201 shares of the basic materials company’s stock valued at $379,000 after buying an additional 16 shares during the last quarter. Lee Financial Co raised its holdings in shares of Monsanto by 0.3% in the second quarter. Lee Financial Co now owns 6,067 shares of the basic materials company’s stock valued at $718,000 after buying an additional 17 shares during the last quarter. Finally, Savant Capital LLC raised its holdings in shares of Monsanto by 0.6% in the second quarter. Savant Capital LLC now owns 3,102 shares of the basic materials company’s stock valued at $367,000 after buying an additional 20 shares during the last quarter. 75.70% of the stock is owned by hedge funds and other institutional investors.

Shares of Monsanto Company (MON) traded up $0.26 during trading on Monday, hitting $119.19. 888,134 shares of the stock were exchanged, compared to its average volume of 1,961,335. Monsanto Company has a twelve month low of $103.08 and a twelve month high of $122.79. The company has a current ratio of 1.35, a quick ratio of 0.83 and a debt-to-equity ratio of 1.12. The firm has a market capitalization of $52,352.99, a price-to-earnings ratio of 21.51, a price-to-earnings-growth ratio of 1.71 and a beta of 1.04.

Monsanto (NYSE:MON) last issued its quarterly earnings results on Wednesday, October 4th. The basic materials company reported $0.20 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.41) by $0.61. Monsanto had a net margin of 15.44% and a return on equity of 42.40%. The business had revenue of $2.69 billion for the quarter, compared to analyst estimates of $2.51 billion. During the same period in the previous year, the business posted $0.07 earnings per share. The business’s revenue was up 4.8% compared to the same quarter last year. equities analysts forecast that Monsanto Company will post 5.74 EPS for the current fiscal year.

In other Monsanto news, COO Brett D. Begemann sold 22,640 shares of the company’s stock in a transaction dated Monday, September 25th. The shares were sold at an average price of $120.03, for a total transaction of $2,717,479.20. Following the transaction, the chief operating officer now directly owns 85,439 shares in the company, valued at $10,255,243.17. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, EVP Steven Mizell sold 11,526 shares of the company’s stock in a transaction dated Monday, October 9th. The stock was sold at an average price of $119.70, for a total transaction of $1,379,662.20. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 49,236 shares of company stock worth $5,931,934. Company insiders own 0.79% of the company’s stock.

A number of equities research analysts have recently commented on MON shares. Piper Jaffray Companies set a $128.00 target price on shares of Monsanto and gave the company a “buy” rating in a report on Friday, August 11th. UBS cut shares of Monsanto from a “buy” rating to a “neutral” rating and set a $128.00 target price for the company. in a report on Friday, August 18th. BidaskClub raised shares of Monsanto from a “sell” rating to a “hold” rating in a report on Saturday, August 19th. Zacks Investment Research raised shares of Monsanto from a “hold” rating to a “buy” rating and set a $131.00 target price for the company in a report on Tuesday, August 29th. Finally, BMO Capital Markets reaffirmed a “buy” rating and issued a $128.00 target price on shares of Monsanto in a report on Friday, September 1st. Eleven analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The stock presently has an average rating of “Hold” and a consensus target price of $124.61.

COPYRIGHT VIOLATION NOTICE: This report was published by Watch List News and is the sole property of of Watch List News. If you are accessing this report on another domain, it was stolen and reposted in violation of U.S. and international copyright and trademark laws. The correct version of this report can be accessed at https://www.watchlistnews.com/monsanto-company-mon-stake-lessened-by-kbc-group-nv/1743390.html.

About Monsanto

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.

Want to see what other hedge funds are holding MON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Monsanto Company (NYSE:MON).

Institutional Ownership by Quarter for Monsanto (NYSE:MON)

Receive News & Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related companies with Analyst Ratings Network's FREE daily email newsletter.